Leishmania Immunity: Advancing Immunotherapy and Vaccine Development

NM Ikeogu, GN Akaluka, CA Edechi, ES Salako… - Microorganisms, 2020 - mdpi.com
Parasitic diseases still constitute a major global health problem affecting billions of people
around the world. These diseases are capable of becoming chronic and result in high …

Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets

D Kumari, S Mahajan, P Kour, K Singh - Life sciences, 2022 - Elsevier
Leishmaniasis is a neglected tropical disease and remains a global concern for healthcare.
It is caused by an opportunistic protozoan parasite belonging to the genus Leishmania and …

Transcriptome, proteome and draft genome of Euglena gracilis

TGE Ebenezer, M Zoltner, A Burrell, A Nenarokova… - BMC biology, 2019 - Springer
Background Photosynthetic euglenids are major contributors to fresh water ecosystems.
Euglena gracilis in particular has noted metabolic flexibility, reflected by an ability to thrive in …

A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis

TLVDP Ostolin, MR Gusmão, FAS Mathias… - Cellular …, 2022 - Elsevier
The development of an immunogenic, effective, and safe vaccine is essential as an
alternative for disease control. The present study aimed to evaluate the immunogenicity and …

Assessment of vaccine-induced immunity against canine visceral leishmaniasis

J Moreno - Frontiers in veterinary science, 2019 - frontiersin.org
Canine visceral leishmaniasis is an increasingly important public health problem. Dogs
infected by Leishmania infantum are the main domestic reservoir of the parasite and play a …

Role of CD8+ T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals

H Kaushal, R Bras-Gonçalves, NS Negi… - BMC Infectious …, 2014 - Springer
Background Majority of individuals with history of visceral leishmaniasis (VL) exhibit strong
immunity to re-infection, however, the mechanism of resistance is poorly understood. It is …

Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients

E Carrillo, N Carrasco-Antón… - PLoS neglected …, 2015 - journals.plos.org
Spain has one of the world's largest pools of organ donors and is a global leader in terms of
the number of transplants it performs. The current outbreak of leishmaniasis in Fuenlabrada …

New Approaches to the Prevention of Visceral Leishmaniasis: A Review of Recent Patents of Potential Candidates for a Chimeric Protein Vaccine

DS Oliveira, MF Zaldívar, AAM Gonçalves, LA Resende… - Vaccines, 2024 - mdpi.com
The development of prophylactic vaccines is important in preventing and controlling
diseases such as visceral leishmaniasis (VL), in addition to being an economic measure for …

Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis

E Petitdidier, J Pagniez, J Pissarra, P Holzmuller… - npj Vaccines, 2019 - nature.com
Dogs are the main reservoir of zoonotic visceral leishmaniasis. Vaccination is a promising
approach to help control leishmaniasis and to interrupt transmission of the Leishmania …

[HTML][HTML] Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic

AV Ibarra-Meneses, E Carrillo, C Sánchez… - Clinical Microbiology …, 2016 - Elsevier
No field method exists for identifying asymptomatic individuals in areas where Leishmania
infantum is endemic. This work reports that, 24 h after stimulating whole blood with soluble …